Thomas M Tzschentke Selected Research

Thomas M Tzschentke Research Topics

Disease

17	Pain (Aches) 01/2021 - 04/2002
9	Neuralgia (Stump Neuralgia) 05/2018 - 07/2009
8	Hyperalgesia 01/2021 - 02/2010
5	Chronic Pain 01/2021 - 10/2007
3	Diabetic Neuropathies (Diabetic Neuropathy) 05/2015 - 06/2014
3	Substance-Related Disorders (Drug Abuse) 11/2014 - 12/2007
2	Acute Pain 05/2022 - 01/2020
2	Colitis 01/2019 - 10/2007
2	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 10/2018
2	Arthritis (Polyarthritis) 08/2018 - 11/2011
2	Hypersensitivity (Allergy) 11/2017 - 03/2011
1	Neoplasms (Cancer) 01/2021
1	Visceral Pain 01/2019
1	Pancreatitis 01/2019
1	Constipation 10/2018
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Opioid-Related Disorders (Opiate Addiction) 11/2014
1	Neuroblastoma 08/2014
1	Bone Neoplasms (Bone Cancer) 06/2014
1	Rheumatoid Arthritis 06/2014
1	Nociceptive Pain 06/2014
1	Inflammation (Inflammations) 11/2011
1	Cocaine-Related Disorders (Cocaine Addiction) 04/2002

Drug/Important Bio-Agent (IBA)

13	Tapentadol FDA Link 01/2020 - 10/2007
11	Opioid Analgesics (Opioids)IBA 05/2022 - 12/2005
10	Analgesics (Analgesic Drugs)IBA 01/2021 - 10/2007
10	Opioid Receptors (Opioid Receptor)IBA 05/2018 - 03/2011
6	NociceptinIBA 01/2021 - 04/2011
6	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2019 - 06/2014
6	Morphine (MS Contin)FDA LinkGeneric 01/2018 - 02/2010
6	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2013 - 09/2010
4	Streptozocin (Streptozotocin)FDA Link 11/2017 - 02/2010
3	Peptides (Polypeptides)IBA 01/2021 - 10/2014
3	Opioid Peptides (Opioid Peptide)IBA 08/2018 - 10/2014
2	Freund's AdjuvantIBA 08/2018 - 11/2011
2	Naloxone (Narcan)FDA LinkGeneric 01/2018 - 11/2011
2	Buprenorphine (Subutex)FDA LinkGeneric 11/2014 - 04/2002
2	Methadone (Dolophine)FDA LinkGeneric 11/2014 - 04/2002
2	Tramadol (K315)FDA LinkGeneric 07/2012 - 03/2011
2	CarrageenanIBA 11/2011 - 03/2011
2	Oxycodone (Oxycontin)FDA LinkGeneric 09/2011 - 03/2011
2	Pregabalin (Lyrica)FDA Link 09/2011 - 03/2011
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2020
1	dibutyldichlorotinIBA 01/2019
1	Drug Receptors (Drug Receptor)IBA 10/2018
1	Illicit Drugs (Recreational Drugs)IBA 11/2014
1	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 10/2014
1	(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA 10/2014
1	Opiate AlkaloidsIBA 05/2014
1	Controlled SubstancesIBA 07/2012
1	Phenol (Carbolic Acid)FDA Link 11/2011
1	Formaldehyde (Formol)FDA Link 11/2011
1	Yohimbine (Yocon)IBA 11/2011
1	Drug CombinationsIBA 09/2011
1	Ibuprofen (Motrin)FDA LinkGeneric 03/2011
1	mu Opioid Receptors (mu Opioid Receptor)IBA 09/2010
1	Cocaine (Cocaine HCl)IBA 12/2007
1	Nicotine FDA Link 12/2007
1	pyridineIBA 12/2007
1	Ethanol (Ethyl Alcohol)IBA 12/2007
1	Antidepressive Agents (Antidepressants)IBA 12/2005
1	Heroin (Diamorphine)IBA 04/2002

Therapy/Procedure

5	Analgesia 10/2018 - 09/2010
4	Ligation 05/2018 - 10/2007
2	Therapeutics 11/2014 - 07/2009
1	Intravenous Administration 01/2019
1	Intra-Articular Injections 08/2018
1	Oral Administration 06/2014
1	Self Administration (Administration, Self) 12/2007